Intervention

Didanosine

ClinicalTrials.gov intervention label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 111 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials111
Recruiting0
Common conditions15
Lead sponsors shown15
Advertisement

Clinical trials

60 shown
Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited SettingsNCT00091936 · 2009-08-01
COMPLETED
Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at BirthNCT00102960 · 2005-07-01
COMPLETED
Study to Evaluate Changes in CD4 on Replacing TDF With ABC or DDI+TDF With ABC+3TCNCT00338390 · 2005-04-01
COMPLETED
Preventing Sexual Transmission of HIV With Anti-HIV DrugsNCT00074581 · 2005-02-01
COMPLETED
A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected PatientsNCT00002207 · 2004-02-01
COMPLETED
Antiretroviral Therapy for Advanced HIV Disease in South AfricaNCT00342355 · 2004-01-01
COMPLETED
HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)NCT00192660 · 2003-02-01
COMPLETED
A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV DrugsNCT00006208 · 2000-08-01
UNKNOWN
Differences Between Women and Men Taking a Combination of Indinavir, Ritonavir, Enteric-Coated Didanosine, and Stavudine Who Previously Took Anti-HIV DrugsNCT00006397 · 2000-08-01
UNKNOWN
Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV DrugsNCT00005000 · 1999-12-01
UNKNOWN
Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug RegimenNCT00002429 · 1999-07-01
COMPLETED
Safety and Effectiveness of a Combination Anti-HIV Drug TreatmentNCT00005018 · 1999-07-01
COMPLETED
Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected AdultsNCT00002427 · 1999-05-01
COMPLETED
Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV DrugsNCT00002240 · 1999-03-01
COMPLETED
Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)NCT00002224 · 1999-03-01
COMPLETED
A Study Comparing Two Forms of Didanosine in HIV-infected PatientsNCT00002360 · 1999-03-01
COMPLETED
A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV DrugsNCT00002411 · 1998-03-01
COMPLETED
A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV InfectionNCT00002176 · 1997-05-01
COMPLETED
A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV InfectionNCT00002177 · 1997-05-01
COMPLETED
A Phase I Safety, Efficacy, and Pharmacokinetic Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Patients With AIDS or AIDS Related ComplexNCT00000710
COMPLETED
A Comparison of Three Treatments for Advanced HIV Disease in Patients Who Have Received Nucleoside Therapy in the PastNCT00001029
COMPLETED
A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and DidanosineNCT00000770
COMPLETED
Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)NCT00000810
COMPLETED
Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315NCT00000891
COMPLETED
A Comparison of Zidovudine (AZT) Used Alone or in Combination With Didanosine (ddI) or Dideoxycytidine (ddC) in HIV-Infected PatientsNCT00001022
COMPLETED
A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI)NCT00000742
COMPLETED
The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 WeeksNCT00001063
COMPLETED
Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or DidanosineNCT00000838
COMPLETED
A Prospective, Randomized, Open-Label, Comparative Trial of Dideoxyinosine (ddI) Versus Dideoxycytidine (ddC) in HIV-Infected Patients Who Are Intolerant of or Who Have Failed Zidovudine (AZT) TherapyNCT00000969
COMPLETED
Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI MonotherapyNCT00000831
COMPLETED
A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)NCT00000781
COMPLETED
Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the DiseaseNCT00001045
COMPLETED
A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination TherapyNCT00000803
COMPLETED
Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected ChildrenNCT00000851
COMPLETED
A Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT, and ddI or ddCNCT00000753
COMPLETED
A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV DiseaseNCT00000656
COMPLETED
Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia ComplexNCT00000657
COMPLETED
A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3NCT00000625
COMPLETED
A Randomized Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected ChildrenNCT00000637
COMPLETED
A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual DosesNCT00001108
COMPLETED
Safety and Effectiveness of an Anti-HIV Drug Combination With and Without Hydroxyurea in Patients With Early HIV InfectionNCT00006339
WITHDRAWN
Comparison of Anti HIV Drugs Used Alone or in Combination With Cytosine Arabinoside to Treat Progressive Multifocal Leukoencephalopathy (PML) in HIV-Infected PatientsNCT00001048
COMPLETED
The Effectiveness of Two Anti-HIV Treatments in HIV-Infected PatientsNCT00001057
COMPLETED
Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIVNCT00051090
WITHDRAWN
Evaluation of Patients Who Have Not Had Success With ZidovudineNCT00001025
COMPLETED
Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV PatientsNCT00007202
COMPLETED
The Safety and Effectiveness of Hydroxyurea and ddI Used Individually or Together in HIV-Infected PatientsNCT00001074
COMPLETED
The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV DrugsNCT00001087
COMPLETED
A Study of Didanosine Use Alone or in Combination With Zidovudine in Infants Exposed to or Infected With HIVNCT00001049
COMPLETED
The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's SarcomaNCT00001114
COMPLETED
Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug TherapyNCT00008866
WITHDRAWN
The Effects of Anti-HIV Drugs in HIV-Infected Patients Who Do Not Have AIDSNCT00001024
COMPLETED
A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior TreatmentNCT00000902
COMPLETED
A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's SarcomaNCT00000954
COMPLETED
A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their BloodNCT00000916
COMPLETED
A Phase I Trial to Evaluate Didanosine (ddI) in HIV-Infected Pregnant WomenNCT00000839
COMPLETED
A Study to Compare Two Different Anti-HIV Drug RegimensNCT00000924
COMPLETED
A Study of Dideoxyinosine (ddI) in HIV-Infected Children Who Have Not Had Success With Zidovudine or Who Cannot Take ZidovudineNCT00000963
COMPLETED
A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T CellsNCT00000822
COMPLETED
A Study to Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels of HIV in the Blood as Low as PossibleNCT00000939
COMPLETED

Trial status mix

COMPLETED101
UNKNOWN5
WITHDRAWN3
TERMINATED2

Phase mix

PHASE242
PHASE127
NA21
PHASE315
PHASE46
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.